These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33823461)

  • 1. White Matter Hyperintensity and Cardiovascular Disease Outcomes in the SPRINT MIND Trial.
    Sheibani N; Wong KH; Turan TN; Yeatts SD; Gottesman RF; Prabhakaran S; Rost NS; de Havenon A
    J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105764. PubMed ID: 33823461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study.
    Chappell FM; Del Carmen Valdés Hernández M; Makin SD; Shuler K; Sakka E; Dennis MS; Armitage PA; Muñoz Maniega S; Wardlaw JM
    Trials; 2017 Feb; 18(1):78. PubMed ID: 28222778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.
    Cloonan L; Fitzpatrick KM; Kanakis AS; Furie KL; Rosand J; Rost NS
    Atherosclerosis; 2015 May; 240(1):149-53. PubMed ID: 25795555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.
    Attar A; Sayadi M; Jannati M
    Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.
    Zhang CR; Cloonan L; Fitzpatrick KM; Kanakis AS; Ayres AM; Furie KL; Rosand J; Rost NS
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):649-54. PubMed ID: 25576348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Nocturnal Heart Rate with White Matter Hyperintensity Burden in Cerebral Small Vessel Disease Patients.
    Yu L; Li Y; Wang Y; Gao Y; Li S; Yu W; Zhao Z; Zong C
    Curr Neurovasc Res; 2021; 18(5):565-571. PubMed ID: 34970952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic Blood Pressure Is Associated With Regional White Matter Lesion Load: The Northern Manhattan Study.
    Caunca MR; Simonetto M; Cheung YK; Alperin N; Lee SH; Elkind MSV; Sacco RL; Rundek T; Wright CB
    Stroke; 2020 Feb; 51(2):372-378. PubMed ID: 31910743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
    Weiner DE; Gaussoin SA; Nord J; Auchus AP; Chelune GJ; Chonchol M; Coker L; Haley WE; Killeen AA; Kimmel PL; Lerner AJ; Oparil S; Saklayen MG; Slinin YM; Wright CB; Williamson JD; Kurella Tamura M;
    Am J Kidney Dis; 2017 Sep; 70(3):357-367. PubMed ID: 28606731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients.
    Rist PM; Buring JE; Rexrode KM; Cook NR; Rost NS
    Eur J Epidemiol; 2019 Oct; 34(10):957-965. PubMed ID: 31399938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
    Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
    Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
    Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
    PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in the Prediction of Cerebrovascular Events With White Matter Hyperintensity.
    de Havenon A; Smith EE; Sharma R; Falcone GJ; Bangad A; Prabhakaran S; Sheth KN
    J Am Heart Assoc; 2023 Jul; 12(13):e029374. PubMed ID: 37345754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Albuminuria With White Matter Hyperintensities Volume on Brain Magnetic Resonance Imaging in Elderly Japanese　- The Hisayama Study.
    Yamasaki K; Hata J; Furuta Y; Hirabayashi N; Ohara T; Yoshida D; Hirakawa Y; Nakano T; Kitazono T; Ninomiya T
    Circ J; 2020 May; 84(6):935-942. PubMed ID: 32269184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency of associations of systolic and diastolic blood pressure with white matter hyperintensities: A meta-analysis.
    Wilkinson I; Webb AJS
    Int J Stroke; 2022 Mar; 17(3):291-298. PubMed ID: 34427478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Intensive Blood Pressure Control in Patients with Evident Cardiovascular Disease: An Investigation Using the SPRINT Study Data.
    Vlachopoulos C; Terentes-Printzios D; Aznaouridis K; Ioakeimidis N; Xaplanteris P; Lazaros G; Tousoulis D
    Curr Vasc Pharmacol; 2019; 17(3):298-306. PubMed ID: 29512468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious Adverse Events Cluster in Participants Experiencing the Primary Composite Cardiovascular Endpoint: A Post Hoc Analysis of the SPRINT Trial.
    Botchway A; Buhnerkempe MG; Prakash V; Al-Akchar M; Adekola B; Flack JM
    Am J Hypertens; 2020 May; 33(6):528-533. PubMed ID: 31930338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
    Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brainstem leukoaraiosis independently predicts poor outcome after ischemic stroke.
    Giralt-Steinhauer E; Medrano S; Soriano-Tárraga C; Mola-Caminal M; Rasal R; Cuadrado-Godia E; Rodríguez-Campello A; Ois A; Capellades J; Jimenez-Conde J; Roquer J
    Eur J Neurol; 2018 Aug; 25(8):1086-1092. PubMed ID: 29660221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.